Stock Movers: UnitedHealth Drops, Eli Lilly Surges, Netflix Rises

UnitedHealth Group's Significant Decline

• 📉 UnitedHealth Group experienced its most significant drop in 26 years, falling approximately 24% over the past week, with most of the decline occurring on Thursday.
• ⚠️ The company cut its annual forecast and reported its first earnings miss in over a decade, citing rising medical costs that blindsided the company.
• 🏥 Performance was affected by patients seeking care at a higher rate than anticipated and unanticipated changes in its Optimum Health Care delivery business, partly due to US Medicare program changes aimed at limiting revenue-boosting tactics.
• 📊 The adjusted earnings forecast was lowered from $29.50-$30 per share to $26-$26.50 per share.

Eli Lilly's Breakthrough in Weight Management

• 🚀 Eli Lilly was the biggest gainer in the S&P 500, up about 15% for the week, largely driven by its experimental pill.
• 💡 The pill demonstrated success in helping patients shed weight and control blood sugar, performing comparably to Ozempic, a significant advancement in the diabetes and weight management market.
• 💊 This development is seen as a potential "golden goose" or "holy grail" for a pill-based alternative to injectable GLP-1 medications, which can have side effects like GI issues.
• 📈 Analysts predict this could significantly impact the projected $130 billion market for such treatments by the end of the decade.

Netflix's Strategic Growth and Earnings

• 📈 Netflix was the second-best performer in the NASDAQ 100, up 4.5% for the week, even before its earnings report.
• 🎯 Earlier in the week, reports indicated Netflix aims to triple its operating income and double revenue by 2030, targeting $9 billion in ad revenue and 410 million subscribers by the same year.
• 📊 The company reported first-quarter profit exceeding Wall Street forecasts, with earnings rising 25% to $6.61 a share and sales growing 13% to $10.5 billion.
• 📊 For the first time, Netflix did not disclose subscriber numbers, shifting investor focus to more traditional financial metrics like profit and sales.